- 全部删除
- 您的购物车当前为空
MAPK-IN-4 (Compound c1) 是一种口服活性的抗炎剂,能够抑制LPS诱导的促炎细胞因子IL-6与TNF-α的表达和释放,并与IRAK4结合,通过抑制MAPK途径实现抗炎效果。
MAPK-IN-4 (Compound c1) 是一种口服活性的抗炎剂,能够抑制LPS诱导的促炎细胞因子IL-6与TNF-α的表达和释放,并与IRAK4结合,通过抑制MAPK途径实现抗炎效果。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
MAPK-IN-4 相关产品
产品描述 | MAPK-IN-4 (Compound c1) is an orally active anti-inflammatory agent that inhibits the expression and release of pro-inflammatory cytokines IL-6 and TNF-α induced by LPS. It interacts with IRAK4 to exert its anti-inflammatory effects by inhibiting the MAPK pathway. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容